María Villa Carpio Fernández

María Villa Carpio Fernández i

Universidad de Jaén - Jaén / Spain
Others
AD Scientific Index ID: 4335899
University of Jaén
person_outline María Villa Carpio Fernández's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 2021815*2021
2-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...MedRxiv, 2021.06. 15.21258542, 2021307*2021
3-) Use of activated clays in the removal of dyes and surfactants from tannery waste watersAG Espantaleon, JA Nieto, M Fernandez, A MarsalApplied Clay Science 24 (1-2), 105-110, 20032992003
4-) Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trialWW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...The Lancet Respiratory Medicine 7 (1), 46-59, 20193042019
5-) Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisO Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...The Lancet 400 (10349), 359-368, 20222612022